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Opioid receptors are expressed in the vestibular endorgans (afferent neurons and hair
cells) and are activated by the efferent system, which modulates the discharge of action
potentials in vestibular afferent neurons (VANs). In mammals, VANs mainly express
the μ opioid-receptor, but the function of this receptors activation and the cellular
mechanisms by which they exert their actions in these neurons are poorly studied. To
determine the actions of μ opioid receptor (MOR) and cell signaling mechanisms in
VANs, we made perforated patch-clamp recordings of VANs that were obtained from
postnatal days 7 to 10 (P7–10) rats and then maintained in primary culture. The MOR
agonist [D-Ala2, N-Me-Phe4, Gly5-ol]-enkephalin (DAMGO) inhibited the total voltage-gated
outward current; this effect was prevented by the perfusion of a Ca2+-free extracellular
solution. We then studied the voltage-gated calcium current (Ica) and found that DAMGO
Met-enkephalin or endomorphin-1 inhibited the ICa in a dose-response fashion. The effects
of DAMGOwere prevented by the MOR antagonist (CTAP) or by pertussis toxin (PTX). The
use of specific calcium channel blockers showed that MOR activation inhibited T-, L- and
N-type ICa. The use of various enzyme activators and inhibitors and of cAMP analogs
allowed us to demonstrate that the MOR acts through a cAMP dependent signaling
mechanism. In current clamp experiments, MOR activation increased the duration and
decreased the amplitude of the action potentials and modulated the discharge produced
by current injection. Pre-incubation with PTX occludedMOR activation effect. We conclude
that MOR activation inhibits the T-, L- and N-type ICa through activation of a Gαi/o protein
that involves a decrease in AC-cAMP-PKA activity. The modulation of ICa may have an
impact on the synaptic integration, excitability, and neurotransmitter release from VANs.
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INTRODUCTION
The μ opioid receptor (MOR) participates in reward-seeking
behavior, analgesia, physical dependence, and the modulation
of respiratory frequency (Fields, 2011; Raehal et al., 2011). The
MOR is a member of the G protein coupled receptors; it is
predominantly coupled to a Gαi/o protein, which decreases the
adenylyl cyclase activity, thereby lowering the cellular level of
cAMP and the PKA activity (Law, 2011). Among other cel-
lular processes affected by opioid receptors, the MOR modu-
lates voltage-dependent calcium, sodium and potassium channels
(Witkowski and Sulczyk, 2006; Law, 2011).
Since the discovery of opioid peptide expression in the
inner ear by Fex and Altschuler (1981), substantial research has
addressed the expression of opioid peptides in the inner ear.
Studies in the vestibular system showed that opioid peptides
and their receptors are expressed both at the central and at the
peripheral levels. In the vestibular efferent neurons of the dorsal
group of the gerbil brainstem, the expression of Met-enkephalin
and enkephalin precursors was demonstrated (Perachio and
Kevetter, 1989; Ryan et al., 1991). In the vestibular nuclei of dogs,
the immunoreactivity to Met-enkephalin has been identified
(Pego-Reigosa et al., 2000), while preproenkephalin was found
in the magnocellular vestibular nucleus in salmon (Vecino et al.,
1995). Recordings in slices obtained from the medial vestibular
nucleus (MVN) of the rat have shown that delta-opioid receptor
agonists decreased the neuronal tonic discharge (Sulaiman and
Dutia, 1998). Further, the use of preproenkephalin antisense and
naloxone significantly delayed vestibular compensation (Kitahara
et al., 2006).
In the vestibular endorgans, the MOR was found in the
afferent neuron terminals (Popper et al., 2004). In recordings
of the frog vestibular afferent nerve, the local perfusion of
enkephalin decreased the basal resting discharge (Andrianov and
Ryzhova, 1999), whereas in the axolotl vestibule, κ opioid recep-
tor (KOR) activation produced an inhibition of the Ca2+ cur-
rent in hair cells and a postsynaptic facilitation of the afferent
response mediated by MOR (Vega and Soto, 2003). Consistent
with these basic science results, in patients with vestibular alter-
ations, morphine administration decreased nystagmus, and ver-
tigo produced by rotatory stimulation (Rubin and Winston,
1950), while it increased the spontaneous nystagmus in opioid
addicts (Kurnatowski, 1992; Benyamin et al., 2008; Baier et al.,
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2010). The use of a selective KOR agonist (salvinorin-A) in con-
trolled conditions has been found to produce hallucinations with
typical sensations of changes in spatial orientation (Johnson et al.,
2011).
The dynamics of the vestibular endorgans depend on the
interactions between the efferent systemmodulation and the out-
put from hair cells and afferent neurons (Cullen, 2012). After
unilateral vestibular damage, balance is partially recovered after
approximately one month (Beraneck and Idoux, 2012). In this
process, the efferent system may contribute to gain readjust-
ment between both labyrinths; opioid peptides, along with other
neurotransmitters such as ACh and CGRP, appear to play a fun-
damental role in readjusting the gain of the system (Perachio and
Kevetter, 1989; Ryan et al., 1991; Holt et al., 2011).
Preliminary results from our laboratory showed that MOR
activation affects the voltage-gated calcium current (ICa) in the
afferent neurons, while other ionic currents are not significantly
modified by the use of MOR related drugs. Voltage-gated cal-
cium channels are susceptible to modulation by opioid receptor
activation. While a large number of works address the modula-
tion of high voltage activated calcium channels (HVA) (Bourinet
et al., 1996; Rusin and Moises, 1998; Connor et al., 1999; Margas
et al., 2007; Lemos et al., 2012), few reports have focused on the
modulation of the low voltage activated calcium channels (LVA)
(Schroeder et al., 1991; Formenti et al., 1995; Yang et al., 2000).
The signaling mechanism implicated in the opioid receptor mod-
ulation of calcium channels includes voltage-dependent (VD) and
voltage-independent (VI) mechanisms (Dascal, 2001). The VD
mechanism entails the Gβγ subunit and supports the willing-
reluctance mode of the calcium channels. The VI mechanism
involves diffusible second messengers, generally cAMP; however,
there is increasing evidence that the Gβγ can modulate other
second messengers apart from cAMP (Smrcka, 2008).
The aim of this work was to determine the opioid receptor
function, the cell signaling mechanisms of MOR modulation and
the type of ICa modulated by MOR in the vestibular primary
afferent neurons.
MATERIALS AND METHODS
Animal care and procedures were in accordance with the APS’s
Guiding Principles in the Care and Use of Vertebrate Animals in
Research and Training and the “Reglamento de la Ley General de
Salud en Materia de Investigación para la Salud of the Secretaría
de Salud de México.” All efforts were made to minimize animal
suffering and to reduce the number of animals used, as outlined in
the “Guide for the Care and Use of Laboratory Animals” issued by
the National Academy of Sciences. Animals were supplied by the
“Claude Bernard” animal house of the Autonomous University of
Puebla.
PRIMARY CULTURE OF VESTIBULAR AFFERENT NEURONS (VAN)
Long-Evans rats from postnatal days 7 to 10 (P7–10) with-
out sex distinction were used for the experiments. Animals
were anesthetized using sevoflurane and euthanized by decap-
itation. The head was cleaned rigorously with 75% ethanol.
The inferior maxilla was removed, and the upper part of the
skull and the brain were removed. The vestibular ganglia were
identified, dissected and placed in Leibovitz medium (L-15) to
proceed with enzymatic and mechanical dissociation (Soto et al.,
2002). To dissociate the ganglia, we used 1.25mg/ml trypsin and
1.25mg/ml collagenase type IA dissolved in L-15 medium. A fire-
polished Pasteur pipette was used to homogenize the tissue; the
homogenate was then centrifuged at 2500 × g for 5min. The
supernatant was discarded, and the procedure was repeated two
additional times. The isolated ganglia neurons were plated on
cover slides pretreated with 100μg/mL poly-D-lysine (Sigma–
Aldrich, St. Louis, MO) in 35-mm Petri dishes (Corning, Lowell,
MA, USA), with 2mL of modified L-15 medium (supplemented
with 10% FBS, 1000 IU penicillin, 15.7mM NaHCO3, 15.8mM
HEPES, and the pH adjusted to 7.7 with NaOH). The cells were
maintained in a 95% air 5% CO2 atmosphere, in a humidi-
fied incubator at 37◦C for 18–24 h until the electrophysiological
record. To study whether the responses observed in P7–10 day old
rats were also present in older rats, an experimental series was also
performed in P28–30 day old rats.
SOLUTIONS
To record the ICa, we used an extracellular solution with the fol-
lowing composition (in mM): 130 TEA-Cl, 10 4-AP, 5 CsCl, 2.5
CaCl2, 10 HEPES and 10 glucose; the pH was adjusted to 7.4 with
HCl. The pipette solution had (in mM): 130 CsCl, 10 TEA-Cl,
10 EGTA, 15 HEPES and 0.134 CaCl2; the pH was adjusted to
7.2 with CsOH. For the current clamp experiments and for the
recording of the voltage-gated total current, we used a normal
extracellular solution with the following composition (in mM):
140 sodium isothianate, 5.4 potassium gluconate, 1.8 CaCl2, 1.2
MgCl2, 10 HEPES and 10 glucose; the pH was adjusted to 7.4
with NaOH. The pipette was filled with the following solution
(in mM): 125 potassium gluconate, 12 sodium isothianate, 0.134
CaCl2, 10 EGTA, and 10 HEPES; the pH was adjusted to 7.2
with KOH. The osmolarity of the solutions was ∼300 mOsm.
In the intracellular solutions Amphotericin B (300μM) or nys-
tatin (260μM) both from Sigma-Aldrich, Co. (St. Louis, MO,
USA) were dissolved in 2mM DMSO before the recordings and
added to the pipette solutions freshly. Solutions were protected
from light to prevent ionophore degradation.With this procedure
time to reach an input resistance∼= 20Mwas about 25min after
establishing the gigaseal.
DRUGS
The drug application was made by using a gravity-driven
flow system (flow rate of approximately 0.5mL/s) consist-
ing of three square perfusion tubes coupled to a step motor
and an electronically controlled valve system (SF-77B; Warner
Instruments, Hamden, CT, USA). The drugs used were the MOR
agonists [D-Ala2, N-Me-Phe4, Gly5-ol]-enkephalin (DAMGO),
Met-enkephalin and endomorphin-1; the MOR antagonist
H-D-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP); the Gαi/o
protein inhibitor pertussis toxin of Bordetella perussis (PTX);
the adenylyl cyclase activator forskolin; the cAMP analog 8-
Br-cAMP; the phosphodiesterase inhibitor IBMX; the PKA
inhibitor H-89; the phosphatase inhibitor okadaic acid; the PKC
inhibitor NPC15437; the PKC activator porbol-myristate-acetate
(PMA); the N type channel blocker ω-ctx-GVIA; the L type
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channel blocker nifedipine; and the T type channel blocker
NiCl2. The NPC15437 was acquired from Research Biochemical
International (Natick, MA, USA), the okadaic acid fromAlomone
Labs (Jerusalem, Israel), and the remaining drugs were from
Sigma-Aldrich Co. (St. Louis, MO, USA). For stock solutions,
the hydro soluble drugs were diluted in deionized water, and the
non-hydro soluble drugs were diluted in DMSO (0.2% DMSO
final concentration). The ω-ctx-GVIA solution also contained
0.1mg/ml cytochrome C (Sigma) to saturate unspecific binding
sites.
ELECTROPHYSIOLOGICAL RECORDING
Membrane ionic currents and cell-voltage responses were stud-
ied using the perforated-patch voltage-clamp and current-clamp
technique. Experiments were performed at room temperature
(23–25◦C). Ionic currents were recorded using an Axopatch
200 B amplifier (Molecular Devices, Union City, CA, USA).
Command-pulse generation and data sampling were controlled
by the pClamp-10 software (Molecular Devices) using a 16-bit
data acquisition system Digidata 1440 A (Molecular Devices).
Data were sampled at 20 kHz; the low-pass filter was set at 10 KHz
to evaluate the passive properties and at 2 KHz for the current
recordings. The passive properties of the cells (membrane capac-
itance Cm, membrane resistance Rm, access resistance Ra and
time constant τ) were measured on-line with the pClamp pro-
gram with a pulse to 5mV from a holding of −70mV. The series
resistance was electronically compensated to 80%. The recording
electrodes were made from borosilicate-glass capillaries 1.2mm
(TW 120, WPI, Sarasota, FL, USA) with resistances between
1.5 and 3 M once filled with pipette solution. The record-
ing chamber was continuously perfused with the corresponding
extracellular solution.
To create the I-V relationship, we used a protocol of voltage
pulses that ranged from −100 to 50mV, with 200ms durations
and steps of 10mV and 5 s inter sweeps; the holding voltage (VH)
was −100mV or −40mV (to elicit the LVA + HVA or the HVA
currents) as indicated in each experimental series. To determine
the LVA and HVA current in the same sweep, we used a VH
of −80mV followed by a pulse to −50mV of 100ms and then
a pulse to −10mV with a duration of 100ms. To evaluate the
voltage-dependent modulation of the ICa by opioid peptides, we
used a protocol that started from a VH = −80mV and gave two
depolarizing pulses (P1 and P2, both to−10mV, 40ms) separated
by a depolarizing pulse to 80mV during 40ms; in consequence,
the 80mV pulse acts as a prepulse of P2. Thus, if an interaction
between the Gβγ complex and calcium channels is present, the
current caused by P2 should be bigger than that caused by P1,
and P2/P1 > 1. The time between P1 and P2 was 70 or 1065ms
to discard the possibility of an inactivation accumulation of the
Ca2+channels.
In the current clamp recordings, to study the action poten-
tial (AP) waveform, cells were stimulated with a current pulse
injection of 300 pA with a duration of 3ms, followed by 10ms
of zero current and a hyperpolarizing pulse of 200 pA with a
duration of 500ms (to produce a rebound potential). To evalu-
ate the repetitive AP discharge of the afferent neurons, a pulse
of 400 pA and 500ms in duration was used. Cells were also
subjected to sinusoidal stimulation (5Hz and amplitude from
0.2 to 1 nA); the stimulus amplitude was adjusted in order for
the neurons to have an unsaturated response (1 to 1 phase look-
ing between the stimulus and AP discharge were considered as
saturating). Instead, a stimulus amplitude in which cells dis-
charge in some stimulus cycles and not in other cycles (ideally
50%) was chosen. This allows the cell to increase or decrease its
AP discharge when experimentally manipulated (i.e., the use of
drugs).
DATA ANALYSIS
Recordings were analyzed off-line using Clampfit 10.2 (Molecular
Devices) and Sigma Plot 8.0 (Systat Software, Richmond, CA,
USA). To construct the I-V relationship, the current ampli-
tude was measured at the peak current in each voltage and
the voltage error produced by uncompensated series resistance
was corrected (Rca was 11 ± 1m). Leak subtraction proto-
cols were not used, instead a linear fit to the current at voltages
between −100 to −70mV was subtracted from the IV relation-
ship. The junction potential calculated using the Henderson-
Hasselbalch equation was 4.3mV and was compensated. The
current data are presented as the current density (pA/pF). The
conductance (g) was obtained in two ways: (i) it was calculated
from the equation g = IP/(Vr − Ve), where IP: peak current,
Vr: recording voltage, and Ve: equilibrium voltage (obtained
from experimental measurements), (ii) it was directly measured
from tail currents elicited with a protocol that provided a volt-
age pulse from −100 to 50mV (40ms duration,  inter-steps
of 10mV and time inter- sweeps 10 s) from a VH = −80mV;
the tails were normalized with the tail value at 30mV. The
conductance data were fitted with a simple Boltzmann equa-
tion of the form f (x) = [(A1 − A2)/(1 + exp(V − V1/2/S))] +
A2, where A1: initial value, A2: final value, S: Boltzmann con-
stant, V1/2: voltage at which 50% of the current is activated and
V: test voltage. For the LVA conductance, the data between −100
and −40mV were fitted; for the HVA conductance, the val-
ues between −100 and 40mV were fitted omitting the values
from −70 to −40mV.
For the analysis of the AP waveform, the phase diagrams were
plotted (Vm vs. dVm/dt) and measurements made from these dia-
grams. The parameters measured included: the Vm (membrane
voltage at zero current injection), the amplitude (from Vm to the
AP peak), the threshold (value at which dVm/dt changes sud-
denly), the duration at 50% of the amplitude, the maximum
depolarization rate (MDR), the maximum repolarization rate
(MRR) and the post-hyperpolarization amplitude (PHP). For the
pulse-evoked repetitive discharge, we counted the APs produced
by the depolarizing current injection.
In experiments in which drugs were applied, a single drug con-
centration was tested for each cell to assure independency of the
data sampling. For the statistical analyses, a paired Student’s t-test
was used in cases in which the dependent variable was measured
before and after treatment. In the cases in which more than one
treatment was used, a One-Way ANOVA with a Tukey post-hoc
test was used. The significance level was established as α = 0.05.
Data were considered significantly different at P = 0.05. The
results are shown as the means ± s.e.m.
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RESULTS
CURRENTS MODULATED BY MOR ACTIVATION
To evaluate whether MOR activation produced significant mod-
ification of the ionic currents in the VANs, the total current
was registered using a protocol from a VH = −70mV, pulses
from −130 to 50mV in steps of 10mV and a duration of 200ms
every 10 s. The inward current (attributable to Na+ current)
was not modified by DAMGO in a concentration ranging from
1 nM to 10μM (n = 25, P > 0.05). The inward current density
at the IV relationship peak was 385 ± 55 pA/pF under con-
trol conditions and 323 ± 49 pA/pF after the application of
1μM DAMGO (n = 6, P = 0.80) (Figure 1A). The outward K+
current decreased with the DAMGO application. At a poten-
tial of 20mV, the current diminished from 220 ± 22 pA/pF in
controls to 150 ± 20 pA/pF with 1μM DAMGO (n = 7, P <
0.05) (Figures 1A,B). The DAMGO effect in the outward current
was fitted with a concentration dependent curve with IC50 =
600 ± 360 nM (n = 26) (Figure 1C). The DAMGO effect was
completely occluded by naloxone (control current was 192 ±
48 pA/pF vs. naloxone and DAMGO 195 ± 47 pA/pF, n = 5,
P = 0.97) and also by perfusion of a calcium free extracellular
solution (control current was 164 ± 17 pA/pF vs. 161 ± 17 pA/pF
after Ca2+ plus DAMGO, n = 10, P = 0.99) (Figures 1D,E). This
initial approach indicated that the calcium-dependent potas-
sium current (IK,Ca) amplitude decreased as a consequence of
the inhibition of the ICa. For this reason, we decided to study
the modulation of the voltage-gate calcium current by MOR
activation.
CALCIUM CURRENT CHARACTERISTICS IN THE VANs
The ICa was recorded in 187 neurons using solutions designed for
the ICa recording. The Cm of these neurons was 30 ± 1 pF (range
10–62 pF). All neurons had the HVA calcium current, while 68%
of the cells (127/187) also had the inactivating LVA calcium cur-
rent (Figure 2A). The neurons with HVA and LVA currents were
typically larger neurons with a Cm of 32 ± 1 pF (n = 127),
while neurons that expressed only the HVA current were signif-
icantly smaller in size with a Cm of 20 ± 1 pF (n = 60; P <
0.001) (Figure 2B). The current voltage (I-V) curve of the ICa was
studied using two different holding potentials: a hyperpolarized
potential (either −100 or −80mV as indicated in each case) and
a depolarized potential (−40mV). At both VH , the maximum
FIGURE 1 | The MOR activation inhibits an outward current in whole
cell current recording. (A) Traces of whole cell total current showing
inward and outward currents under control conditions and after 1μM
DAMGO perfusion, the fast inward current (mainly attributable to Na+) did
not change, but the outward current (attributable to K+) decreased
significantly. Inset shows the fast inward current in a time expanded scale.
The dotted lines indicate zero current. (B) The current-voltage relationship
for the outward current showed a significant effect of DAMGO which
decreased the maximum current 32% at 20mV. (C) Concentration
response relationship for the DAMGO inhibitory effect on the outward
current was fitted with a Hill equation with a CI50 = 600 nM and Hille
coefficient of 1.2. (D) Voltage clamp recordings of whole cell current under
control condition (black trace). The perfusion with a Ca2+ free extracellular
solution significantly decreased the outward current (gray trace), and the
effect of 1μM DAMGO was completely occluded by perfusion with a Ca2+
free solution (blue trace). The dotted lines indicate zero current. (E) Time
course of outward current amplitude in control, after 10μM naloxone
perfusion, which exerted no effect, but completely occluded the action of
1μM DAMGO, indicating that DAMGO effect is specifically mediated by
opioid receptor activation. ∗Indicates a significant difference P < 0.05.
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FIGURE 2 | HVA and LVA calcium currents in vestibular afferent neurons.
(A) Representative traces of the ICa produced by voltages between −50mV
and 30mV with a VH = −100mV in neurons with HVA current and in those
with both HVA and LVA currents. The dotted lines represent zero current.
(B) Histogram showing the Cm vs. the number of neurons. The neurons with
both HVA and LVA ICa (68%) are distributed across the range of Cm from 9 to
62 pF with a mean of 32 ± 1pF. The neurons with the HVA ICa are distributed
across the range of Cm from 10 to 32 pF with a mean of 20 ± 1pF.
Continuous lines were fit with a normal function with R2 > 0.95. (C) I-V
relationship of the LVA ICa (obtained by subtracting the peak current with
VH = −40mV from that obtained with a VH = −100mV) and HVA ICa.
(measured in cells that expressed the HVA but not the LVA). Because the LVA
current is clearly visible at −50mV with a VH = −100mV and at this voltage
the HVA current is not yet activated, this was the voltage selected to study
the LVA current. (D) Recording of the LVA and HVA components using a
double pulse voltage clamp protocol under control conditions and after the
use of 100μM Ni2+. The use of Ni2+ completely block the LVA component
without significantly modifying the HVA.
current was achieved at a voltage of approximately −10mV. With
the VH = −40mV, the LVA current was not detectable; with the
VH = −100mV, the LVA was clearly distinguishable. The LVA
current activated at −59mV (from a VH = −80mV), had a peak
value of 12 ± 2 pA/pF at −44mV and inactivated with a τ of
58 ± 10ms (n = 13) (Figure 2C). Voltage clamp recording at
two test pulses showed that 100 nM Ni2+ reduce the LVA cur-
rent 92 ± 4% (n = 5, P = 0.002) while the reduction of the HVA
component was 2 ± 5% (P = 0.98) (Figure 2D). Since using a
VH of −100mV the LVA current is already activated at −50mV
(−44mV with Rs and liquid junction potential correction), and
at this voltage the HVA current is not yet active, this was the
voltage selected for measurements of the LVA current. The HVA
current activated at −40mV, had a peak amplitude at −10mV
and partially inactivated (19 ± 3% of the peak value with a τ of
659 ± 110ms, n = 21).
MOR MODULATES BOTH LVA AND HVA ICa
The effects of MOR activation on the ICa were evaluated using
the agonists DAMGO, Met-enkephalin and endomorphin-1.
In P7–10 rats, DAMGO was used in concentrations ranging
from 100 pM to 10μM. DAMGO produced a dose-dependent
inhibition of the ICa with an IC50 of 33 ± 5 nM and with
a Hill coefficient of 1.1 (n = 35; Figures 3A,B). The maxi-
mum inhibition was attained with 1μM DAMGO that inhib-
ited 58 ± 7% of the current at −47mV (LVA) and 35 ±
4% at −14mV (HVA, n = 15, P = 0.01); these results indi-
cate that MOR activation inhibits both the LVA and HVA
Ca2+ current components. Because of these results, the con-
centration of 1μM was selected for further testing MOR
activation.
Conductance curves showed that DAMGO inhibition of the
ICa did not significantly modify the half activation voltage
or the slope of the LVA or HVA current components (LVA:
V1/2 = −55 ± 8mV, S = 7 ± 1 vs. V1/2 = −54 ± 1mV, S = 7 ±
1. HVA: V1/2 = −30 ± 3mV, S = 9 ± 1 vs. V1/2 = −30 ± 3mV,
S = 11 ± 1; Figure 3C).
The actions of 1μMMet-enkephalin and 1μMendomorphin-
1 were also evaluated. Met-enkephalin inhibited the HVA ICa in
15 ± 6% (n = 5, P = 0.04) and endomorphin-1 inhibited the
ICa in 23 ± 8% (n = 5, P = 0.05; Figure 3D). In the LVA, Met-
enkephalin inhibited the ICa in 34 ± 10% (n = 5, P = 0.07) and
endomorphin-1 inhibited the ICa in 38 ± 8% (n = 5, P = 0.04;
Figure 3D).
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FIGURE 3 | MOR activation mediates inhibition of the ICa. (A)
Dose-response curve for DAMGO inhibition of the peak ICa (n = 35). (B) The
control I-V relationship for the ICa (VH = −100mV) showed a complex form
with a hump at −50mV corresponding to the LVA currentand a peak at
approximately −10mV corresponding to the HVA plus LVA current. The
perfusion of 1μM DAMGO inhibited both components of the ICa. (C) The use
of 1μM DAMGO did not significantly modify the parameters of the
Boltzmann fit (V1/2 and S) to the conductance of the LVA or HVA
components. (D) Bar graph showing the inhibitory action of 1μM DAMGO,
1μM Met-enkephalin and 1μM endomorphin-1 on the HVA (measured at the
peak of the I-V relationship) and the LVA (measured at −50mV) components.
(Statistical significance ∗P < 0.05, ∗∗P < 0.01).
MOR ACTION IS PRESERVED DURING DEVELOPMENT
To determine whether the modulation of the ICa by MOR is pre-
served in older ages, an experimental series using P28–30 rats
was performed (this was the only experimental series in which
P28–30 rats were used). The perfusion of 1μMDAMGO in P28–
30 rats inhibited the HVA ICa 28 ± 7% (n = 9, P = 0.03) and
the LVA ICa36 ± 9% (n = 6, P = 0.02, Figure 3D). The inhibi-
tion produced by DAMGO at both ages (P7–10 vs. P28–30) was
not significantly different for the HVA current (P = 0.30) but was
significantly lower for the LVA in P28–30 rats (P = 0.04); these
findings suggest that the LVA current decreased with age or that
the LVA current uncouples from the second messenger system in
older ages; changes in theMOR expression or sensitivity should in
principle be reflected in both the LVA or the HVA current compo-
nents. Because the ICa density did not change between the P7–10
and the P28–30 (12 ± 2 pA/pF and 11 ± 1 pA/pF) groups, these
results showed that the inhibitory effects of MOR in the calcium
current persisted with age, although with small but significant
variation in relation to the LVA current.
HVA ICa SUBTYPES MODULATED BY MOR ACTIVATION
To define the subtypes of Ca2+ currents inhibited, we used a
voltage clamp protocol with a pulse to −50mV (with 100ms
duration, to activate the LVA current), followed by a pulse
to −10mV (with 100ms duration, to activate the HVA cur-
rent) from a VH = −80mV. With this protocol, the perfusion of
1μM DAMGO inhibited 60 ± 10% of the LVA current (n = 5,
P = 0.03); the subsequent co-application of 100μM nickel pro-
duced an additional inhibition reaching a total inhibition of 92 ±
4% of the control current (n = 5, P = 0.02). The inhibition of
the HVA current (measured at −10mV) was 32 ± 6% (n = 9,
P = 0.03), and the co-application of 100μM Ni2+ did not pro-
duce additional changes in the HVA current (97 ± 6%, P = 0.83
with respect to DAMGO effect). These results suggest that MOR
activation partially inhibits both the LVA and HVA components
of the ICa and that 100μM nickel selectively blocks the LVA ICa
component without affecting the HVA component of the current
(Figure 4A).
The HVA component of the ICa in VANs is formed by the
L-, N-, P/Q- and R- calcium channel subtypes (Desmadryl et al.,
1997). To study the HVA calcium channel subtypes inhibited by
MOR activation, we used specific blockers for each HVA com-
ponent. The perfusion of the L-type blocker nifedipine (10μM)
decreased the ICa 21 ± 8% (n = 11, P = 0.03); the subsequent
co-application of 1μM DAMGO additionally decreased the ICa
17 ± 8% for a total inhibition of 38 ± 8%, indicating that
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FIGURE 4 | Calcium current modulation by MOR activation.
(A) Representative traces of the ICa in neurons with (right) and without
(left) LVA current. Two-pulse voltage protocol (shown below) evidenced the
LVA and HVA currents. Use of 1μM DAMGO inhibited both ICa
components. Nickel (100μM) blocked the LVA current without affecting the
HVA component. The dotted line represents zero current. (B) Time course
of the HVA current in the control and after the application of 3μM
ω-ctx-GVIA, followed by 10μM nifedipine and nifedipine plus 1μM DAMGO
(n = 6; ns, non-significant; ∗P ≥ 0.5). The application of ω-ctx-GVIA and
nifedipine occluded the DAMGO effect. Insert, shows traces of the ICa in
the control condition and with sequential application of ω-ctx-GVIA (gray),
nifedipine (light gray) and the co-application of nifedipine and DAMGO
(blue). Calibration bars 500 pA, 10ms. (C) Bar graph showing the various
experimental conditions used to discern the subtype of Ca2+ channels
coupled to MOR activation, including: 1- DAMGO, 2- ω-ctx-GVIA, 3-
DAMGO +ω-ctx-GVIA, 4- nifedipine, 5- nifedipine + DAMGO, 6-
ω-ctx-GVIA + nifedipine, 7- DAMGO +ω-ctx-GVIA + nifedipine. ∗P ≤ 0.05
with respect to the respective control.
nifedipine occluded 47% of the DAMGO effect (n = 11, P =
0.02, ANOVA). The perfusion of the specific N-type calcium
channel blocker ω-ctx-GVIA (3μM) decreased the ICa 20 ± 5%
(n = 5, P = 0.02); the co-application of 1μMDAMGO addition-
ally decreased the ICa 18 ± 7% for a total inhibition of 38 ±
7%, indicating that ω-ctx-GVIA occluded 51% of the DAMGO
effect (n = 5, P = 0.03, ANOVA). To further characterize the
Ca2+ channel subtypes involved in the DAMGO effect, an experi-
mental series was performed in which the co-application of 3μM
ω-ctx-GVIA and 10μM nifedipine inhibited 46 ± 6% of the
ICa, the addition of 1μM DAMGO did not produce any fur-
ther decrease of the remnant ICa (n = 6, P = 0.002, ANOVA)
(Figures 4B,C). It is worth noting that the action of ω-ctx-GVIA
is not reversible; thus, its actions remain during the entire exper-
imental time course, and the effects of the three drugs are added
sequentially. These results showed that MOR activation targets
the L- and the N-type Ca2+ currents. Because the blockade of
the L- and N-type currents fully occluded the DAMGO effect,
no further selective Ca2+ antagonists (R- or P/Q-type) were
tested.
ICa INHIBITION IS MEDIATED BY A Gαi/o
To determine whether the inhibition of the ICa was produced
by the specific activation of the MOR, we studied the DAMGO
effect in the presence of the MOR antagonist CTAP. The perfu-
sion of 10μM CTAP did not, by itself, modify the ICa amplitude
(Figure 5B). Further, the co-application of 10μM CTAP and
1μM DAMGO did not reduce the ICa amplitude (CTAP +
DAMGO 97 ± 1% with respect to the control, n = 9, P =
0.90). The CTAP washout, leaving only DAMGO, produced the
expected decrease in the ICa peak amplitude (35 ± 8%, n = 9,
P = 0.02, ANOVA; Figures 5A,B).
In an experimental series designed to demonstrate the par-
ticipation of the Gαi/o protein activation in the ICa inhibition
produced by MOR activation, cultured VANs were incubated for
20 h with 500 ng/ml PTX. Afterwards, the perfusion of 1μM
DAMGO did not produce significant changes in the LVA cur-
rent (P = 0.35). In contrast to the typical DAMGO inhibitory
effects on the HVA component of the ICa, DAMGO increased
the HVA ICa 20 ± 7% (n = 10, P = 0.02) (Figures 5C,D). These
results showed that the Gαi/o protein is the transducer between
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FIGURE 5 | CTAP and PTX occluded the inhibition of the ICa produced by
MOR activation. (A) Representative traces of the ICa under control
conditions, 10μM CTAP plus 1μM DAMGO and 1μM DAMGO. The CTAP
had no action when applied alone, but occluded the inhibitory effect of
DAMGO. In this and in the following graphs, the dotted line corresponds to
zero current. (B) The perfusion of 10μM CTAP did not modify the ICa
amplitude. Co-application of CTAP and 1μM DAMGO occluded the inhibitory
effect of DAMGO, while the subsequent washout of CTAP allowed for
DAMGO to inhibit the ICa 35 ± 8%; washout of DAMGO partially recovered
the ICa (ns: P > 0.05, ∗P < 0.05). (C) Traces of ICa in the control and with
1μM DAMGO in a neuron incubated for 20 h with 500 ng/ml PTX. The use of
DAMGO after incubation with PTX slightly increased the ICa (P = 0.015).
(D) The I-V relationship (VH = −100mV) of the ICa in neurons incubated with
PTX and after 1μM DAMGO application. For voltages below −20mV,
DAMGO had no significant effect; for voltages between −20 to 20mV, it
increased the ICa (23 ± 7% at −15mV) (∗P < 0.05; ns: P > 0.05).
MOR activation and LVA ICa inhibition; when the Gαi/o pro-
tein is inhibited, there is evidence of the interaction between the
MOR and other G proteins (see Discussion). No experiments
were performed to characterize the signaling mechanism of the
potentiation produced by DAMGO.
ICa IS NOT MODULATED BY A VOLTAGE-DEPENDENT MECHANISM
To determine whether MOR inhibition of ICa was voltage-
dependent, we used a two-pulse protocol separated by a depolar-
izing pulse. Under control conditions, the P2/P1 ratio was 0.86 ±
0.05; with 1μM DAMGO, the ratio was 0.85 ± 0.05 (the time
between P1 and P2 was 70ms, n = 6, P = 0.55, Figures 6A,B). To
discard the possibility that there was an accumulation of channel
inactivation (Ikeda, 1991), the P2/P1 ratio was also measured in
experiments extending the interval between P1 and P2 to 1065ms.
In this condition, the P2/P1 ratio was 0.93 ± 0.03 in the con-
trol and 0.94 ± 0.04 after DAMGO perfusion (n = 8, P = 0.51)
(Figures 6C,D). Finally, to further confirm whether Ca2+ chan-
nel facilitation was present in the VANs, the P2/P1 ratio with-
and without depolarizing prepulses were evaluated; no significant
differences were found between conditions, indicating that the
channel facilitation was not present (data not show, n = 8, P =
0.86). These results show that in the isolated VANs, the voltage-
dependent mechanism does not participate in the ICa inhibition
by MOR.
MOR EFFECTS ON THE HVA ICa ARE MEDIATED BY A cAMP PATHWAY
To determine whether the voltage-independent signaling mech-
anism was involved in the ICa inhibition by MOR activation, we
evaluated cAMP-pathway and PKC participation. We first list the
results for the HVA and then for the LVA component.
The application of the cAMP permeant analog 8-Br-cAMP
(300μM) enhanced the HVA ICa 33 ± 17% (n = 8, P = 0.02)
and occluded the DAMGO inhibitory effect (n = 8, P = 0.25).
Furthermore, 1mM 8-Br-cAMP reverted the inhibition produced
by 1μM DAMGO on the ICa (recovered 92 ± 7% of the con-
trol HVA, n = 7, P = 0.87) (Figures 7A,B). The perfusion of
the PKA inhibitor H-89 (1μM) mimicked the effects produced
by MOR activation, decreasing the HVA ICa 34 ± 4%; the co-
application of 1μM H-89 and 1μM DAMGO did not added
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FIGURE 6 | The voltage-dependent signaling mechanism did not
participate in the inhibition of the ICa by MOR activation. (A,B) Traces
of the ICa under the control condition and after 1μM DAMGO perfusion.
Protocols to evaluate the voltage-dependent modulation of the ICa
consisted of two depolarizing pulses (P1 and P2, to −10mV) separated by
a depolarizing pulse that acted as a P2 prepulse (to 80mV). (B) Bar graph
showing the value of the P2/P1 ratio under control and after DAMGO.
(C) The time between P1 and the pulse to 80mV was 1 s to avoid
inactivation accumulation. The ratio P2/P1 did not change between the
control and after DAMGO application, independent of the time between P1
and the pulse to 80mV. (D) Bar graph showing the value of the P2/P1
ratio under control and after DAMGO.
their inhibitory effects (n = 6, P = 0.81) (Figure 7C). The use of
okadaic acid (100 nM) shifted the HVA activation curve to less
depolarizing values (the V1/2 was −28 ± 2mV under the con-
trol condition and −35 ± 3mV with okadaic acid, n = 7, P =
0.04) and increased the maximum of the ICa I-V relationship
34 ± 8% (n = 7, P < 0.05). The subsequent co-application of
okadaic acid and 1μM DAMGO returned the V1/2 of the acti-
vation curve to the control values; it decreased the peak of the I-V
relationship 51 ± 4% with respect to the okadaic acid application
and 34 ± 4% with respect to the control (n = 7, P = 0.04 and
P = 0.05, respectively, Figures 7D,E). The adenylyl cyclase acti-
vator forskolin (10μM) enhanced the HVA ICa 21 ± 5% (n = 11,
P = 0.03) and 10μM forskolin prevented the 1μM DAMGO
inhibitory effect (n = 8, P = 0.33). The use of the phosphodi-
esterase inhibitor, 100μM IBMX, reverted the inhibition of the
ICa induced by 1μM DAMGO (recovering 96 ± 6% of the ICa,
n = 6, P = 0.01, Figure 7F).
In contrast to the effects found with the cAMP-pathway related
drugs, the activation or inhibition of PKC were not capable of
modifying the MOR inhibition of the ICa. The application of the
PKC activator PMA (500 nM) enhanced the ICa 31± 16% (n = 5,
P = 0.03). However, PMA perfusion was unable to recover the ICa
from the inhibitory action of 1μM DAMGO (n = 6, P = 0.78).
The perfusion of the PKC inhibitor NPC15437 (200 nM) pro-
duced a significant inhibition of the ICa 12 ± 5% (n = 9, P =
0.01), while NPC15437 added its inhibitory effects with that pro-
duced by 1μM DAMGO for a total inhibition of 42 ± 3% of the
ICa (n = 9, P = 0.01, ANOVA) (Figure 7F).
MOR EFFECTS ON THE LVA ICa ARE MEDIATED BY A cAMP PATHWAY
With respect to the modulation of the LVA component, the use
of 300μM 8-Br-cAMP prevented the inhibition produced by
1μM DAMGO (n = 5, P = 0.50, Figure 7F). The use of 100 nM
okadaic acid enhanced the LVA 86 ± 8% (n = 5, P = 0.02),
while the co-application of DAMGO (1μM) and okadaic acid
(1μM) decreased the current 35 ± 10% with respect to the con-
trol (n = 5, P = 0.05). The use of forskolin (10μM) produced
an enhancement of the current (38 ± 12%, n = 8, P = 0.03),
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FIGURE 7 | Inhibition of the ICa by MOR activation was reverted by
8-Br-cAMP or IBMX and mimicked by H89. (A) Time course of the ICa
amplitude under the control condition, after 1μM DAMGO and DAMGO plus
1mM 8-Br-cAMP application. The application of 8-Br-cAMP reverted the
DAMGO inhibition 92 ± 7% (n = 7). (B) Traces of the ICa under the control
condition, after DAMGO and after the co-application of DAMGO and
8-Br-cAMP. (C) Time course of the ICa peak amplitude under the control
condition, after the use of 1μM H89 and after 1μM H89 plus 1μM DAMGO
perfusion. The H89 mimicked the inhibitory effect of DAMGO; the
co-application of H89 and DAMGO did not add to its inhibitory effects (n = 9).
(D) I-V relationship of calcium current showed that the phosphatase inhibition
with 100 nM okadaic acid enhanced the HVA and LVA currents, shifted the
peak of the IV relationship to less depolarized values, but was unable to
occlude the inhibitory effect of 1μM DAMGO. (E) Representative traces of
the LVA and HVA currents in control, under perfusion with 100 nM okadaic
acid and coapplication of 100 nM okadaic acid and 1μM DAMGO. The
okadaic acid enhanced the ICa but was unable to occlude the DAMGO effect.
The line dotted line represents zero current. The voltage clamp protocol is
shown below the recordings. (F) Bar graph summarizing the effects produced
by the various drugs used to discern the pathways involved in MOR actions
upon both the LVA and HVA current components (∗ means P < 0.05; ns
means P > 0.05).
while the co-application of 10μM forskolin plus 1μM DAMGO
occluded the DAMGO effect (n = 5, P = 0.18, Figure 7F). The
co-application of 100μM IBMX with 1μM DAMGO, after
DAMGO application, recovered the current to 93 ± 5% of the
control (n = 5, P = 0.05). In addition, the inhibition of PKAwith
1μMH89 decreased the LVA current 40 ± 8% (n = 5, P = 0.02),
whereas the subsequent co-application of 1μMDAMGO did not
change the remnant LVA current (n = 5, P = 0.26). Finally, the
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activation of PKC with 500 nM PMA did not significantly modify
the LVA current or revert the DAMGO effect (n = 5, P = 0.95,).
In contrast, the PKC inhibition with 200 nM NPC15437, after
the DAMGO effect (41 ± 5%, n = 7, P = 0.01), added an addi-
tional inhibition of 23 ± 6% in the LVA current (n = 7, P = 0.05,
Figure 7F). These results indicate that the LVA current is inhib-
ited by MOR activation through the cAMP dependent signaling
mechanism in a similar fashion to the mechanism mediating the
HVA current inhibition.
MOR ACTIVATION EFFECTS ON VAN ACTION POTENTIALS
Taking into account the functional role of the IK,Ca (Limón et al.,
2005) and the potential role of the ICa in the setting of dis-
charge patterns of VAN, the actions of MOR activation were also
evaluated in current clamp conditions.
To study the AP morphology, afferent neurons were stimu-
lated with a 300 pA current pulse injection of 3ms. The perfusion
of 1μM DAMGO decreased the AP amplitude from 109 ± 6 to
95 ± 5mV, the MDR from 150 ± 6 to 135 ± 6mV/ms, the MRR
from −46 ± 3 to −39 ± 3mV/ms, and increased the AP duration
from 4 ± 0.5 to 10 ± 4ms (n = 11, P < 0.05 for each parameter)
(Figure 8). In 40% of the neurons studied, DAMGO blocked a
rebound AP discharge after a hyperpolarizing pulse (200 pA dur-
ing 500ms). When the neurons were pretreated with PTX for
20 h, the perfusion of DAMGO (1 and 10μM; n = 4 and n = 3,
respectively) did not produce any significant change in the AP
waveform (P > 0.05) or rebound discharge.
In the neurons that presented pulse-evoked repetitive dis-
charge, DAMGO 1μM decreased the number of APs in 73% of
the neurons (11/15; from 4.7 ± 1 APs in the control condition to
2.6 ± 1 APs after DAMGO). This effect was completely reversible
after drug washout (4.6 ± 1 APs, Figure 8) (n = 11, P = 0.03).
In 3/15 neurons, the perfusion of DAMGO did not modify the
discharge of the APs, and in 1 of the neurons, DAMGO appli-
cation produced an enhancement in the AP discharge from 2
to 3 APs. The after hyperpolarization following the step depo-
larization did not change with the 1μM DAMGO application,
the control was −5.9 ± 4mV and with DAMGO −5.7 ± 4mV
(n = 11, P = 0.49). These results suggest that theMOR activation
did not modify the SK calcium activated potassium current.
To further corroborate that the MOR activation modulates
the ICa an experimental series with Ca2+ free extracellular solu-
tion was performed (Ca2+ was equimolarly substituted byMg2+).
With the perfusion of the Ca2+ free solution there were a decre-
ment of the AP discharge (in 6 of 8 cells), in 2 cells, there was
an enhancement of the AP discharge. The inhibitory or excitatory
action was similar independently of the stimulus protocol (square
pulses or sinusoidal stimulation). The use of 1μM DAMGO in
the Ca2+ free solution did not produce any significant change
in the AP discharge in all the neurons studied (independently of
FIGURE 8 | The morphology and discharge of APs are modulated
by MOR activation. (A) Bar graph of the AP waveform parameters
in the control, with 1μM DAMGO and after drug washout (n = 11).
DAMGO increased the AP duration and decreased the amplitude, the
MDR and the MRR. (B) Representative AP recordings under the
control condition, after DAMGO and the washout of the drug.
(C) Recordings of cell response to depolarizing square current
injection (400 pA, 500ms). DAMGO (1μM) decreased the discharge
frequency of the cell. In (B,C), the dotted line represents zero
voltage. ∗Indicates a significant difference P < 0.05.
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their inhibitory or excitatory tendency after Ca2+ free perfusion),
indicating that the MOR activity is due to the modulation of ICa
(Figure 9A).
With the use of sinusoidal current stimulation of 5Hz (stimu-
lus amplitude selected to produce AP discharge in approximately
50% of the cycles), the use of MOR agonists 1μM DAMGO
(n = 6), 1μM endomorphin-1 (n = 5) or 1μM Met-enkephalin
(n = 6) produced similar effects. In one group of neurons, MOR
agonists decreased the AP discharge per cycle from 0.51 ± 0.07 to
0.23 ± 0.10 (n = 7, P = 0.007), while in the other group of neu-
rons, MOR agonists increased the number of APs per cycle from
0.43 ± 0.07 to 0.81 ± 0.08 (n = 10, P = 0.004) (Figures 9B–D).
The Cm of the neurons in which DAMGO agonists decreased
the discharge was larger (33 ± 4 pF) than those in which an
enhancement of activity was observed (23 ± 3 pF; P = 0.02).
DISCUSSION
We found that all VANs express the HVA ICa and that 68% of the
neurons also express the LVA ICa. The neurons that lacked the LVA
current were significantly smaller than the neurons with both LVA
and HVA currents. The percentage of neurons with LVA current
is comparable (although slightly smaller) to previously reported
values of 74% (Limón et al., 2005) and 81% (Desmadryl et al.,
1997). The difference, although small, may be due to the larger
sample size in this study (187 neurons) and to differences in the
species studied (Wistar rats P7–10, Swiss rats P4-P8, and, in our
case, Long Evans P7–10).
The VANs express voltage gated calcium channels of the T-,
L-, N-, P/Q- and R- types (Desmadryl et al., 1997; Chambard
et al., 1999; Autret et al., 2005; Limón et al., 2005; Meredith
et al., 2011). The modulation of the HVA and LVA ICa currents
influence the VAN excitability, thus modulating the vestibular
output; our results showed that the T-, L- and N-type chan-
nels are modulated by MOR. In the VANs, the N-type current
may be mostly related to neurotransmitter release at the vestibu-
lar nucleus neurons. The L-type current may participate in the
calcium transients in the cell body and dendrites of the vestibu-
lar neurons (Meredith et al., 2011). Further, the L-type current
may modulate gene expression (Catterall, 2011). The T-type cur-
rent may affect the synaptic integration of calyx endings and also
contribute to the differences between the regular and irregular
discharge of the VANs (Autret et al., 2005). This suggests that the
MOR may participate in regulating the gain of the afferent neu-
rons contributing to maintain the strict output balance from the
vestibular endorgans.
The IC50 of the DAMGO effect in our experiments was in
the nanomolar range, which is similar to that reported in other
isolated primary neurons, such as the nodose superior cervi-
cal or trigeminal ganglion neurons (Rusin and Moises, 1998;
Margas et al., 2007). The DAMGO effect did not affect the
voltage dependence or the activation voltage of the ICa, indi-
cating that the inhibition was due to a decrease in the channel
open probability and not to a modification of channel kinetic
properties.
FIGURE 9 | Current clamp response to sinusoidal stimulation and MOR
activation. (A) A depolarizing current pulse injection (50 pA) produced a
repetitive firing of the neuron The perfusion of VAN with Ca2+ free
solution significantly decreased the AP discharge, the subsequent
application od DAMGO did not further modified the AP discharge.
(B) Typical response to sinusoidal current injection (5Hz, 200 pA, shown
below the record). Before the stimuli, the cells were held at −60mV. In
one group of cells, 1μM endomorphin-1 decreased the APs per cycle.
(C) In a second group of neurons, endomorphin-1 enhanced the number of
APs per cycle. (D) Bar graph showing the mean number of APs per
stimulus cycle in the control (white bars) and after MOR agonist
application for the cells in which the MOR agonists decreased (blue) and
increased (red) the AP discharge. Drug effect was partially reversible after
washout of the drug (gray). (∗means P < 0.05, ∗∗means P < 0.01).
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Both the HVA and LVA Ca2+ currents were modulated by
MOR in the VANs. TheHVAmodulation byMOR has been found
in several neuronal types (Rusin and Moises, 1998; Connor et al.,
1999; Lemos et al., 2012) and in heterologous expression systems
(Bourinet et al., 1996; Margas et al., 2007). However, there are
only a few reports that have shown a modulation of the LVA cur-
rent by MOR activation (Schroeder et al., 1991; Formenti et al.,
1995; Yang et al., 2000). The magnitude of HVA modulation by
MOR varies in different neuronal types. In our case, the inhibition
(35%) was similar to that found in the periaqueductal gray neu-
rons (Connor et al., 1999) and nodose ganglion neurons (Rusin
and Moises, 1998) and was significantly lower than the 64% inhi-
bition reported in superior cervical ganglion neurons (Margas
et al., 2007); these differences may be due to the subtypes of HVA
Ca2+ channels involved or to intracellular signaling mechanism
specificities. In the case of the LVA ICa, the percentage of inhibi-
tion in the VANs by MOR activation was 58% in the P7–10 rats.
This is larger than data previously reported for the modulation
of the LVA by MOR activation in dorsal root ganglion neurons
of the rat (∼= 35%), thalamic relay neurons (40%) and neurob-
lastoma cells N1E115 (∼= 20%) (Schroeder et al., 1991; Formenti
et al., 1995; Yang et al., 2000). The effects of MOR activation in
P28–30 rats in our experiments (36%) were closer to the values
reported in the mentioned systems.
In our experiments, the action of DAMGO was prevented by
the specific MOR antagonist CTAP, suggesting that the DAMGO
effect is specifically due to MOR activation (Abbruscato et al.,
1997; Margas et al., 2007). In addition, the inhibition of the Gαi/o
protein with PTX prevented the inhibitory effects on the LVA
and HVA Ca2+ current components. It is noteworthy that the
Gαi/o inhibition by PTX inverted the action of MOR activation
in the HVA Ca2+ current; thus, DAMGO application produced
an enhancement of the HVA ICa. This positive modulation of the
HVA ICa may be due to the interaction of the opioid receptor
with Gα proteins other than Gαi/o (Cruciani et al., 1993) or as
consequence of the modulation by Gβγ of the calcium channels
(Smrcka, 2008). While the Gαs may be involved in the enhance-
ment of the HVA ICa, there are no specific antagonists of this
G-protein. Further, the use of GDP-β-S, which is an unspecific
G protein inhibitor, implies rupturing the cell patch; this pro-
duces a condition in which the ICa has a significant rundown
that very quickly reduces the experimental reliability, thus mak-
ing it useless. In further examination of the signaling mechanism
involved in the ICa modulation by MOR, we found that the VANs
Ca2+ channels were in a non-saturated level of phosphoryla-
tion susceptible to either positive or negative modulation in our
experimental conditions.
The signaling mechanism involved in the ICa modulation by
MOR may be voltage-dependent (VD) or voltage- independent
(VI) (Law, 2011). In the VANs, the VD mechanism did not par-
ticipate in the ICa inhibition by MOR, similar to what has been
found in the globus pallidus neurons (Stefani et al., 2001). The
lack of VD modulation in the VANs may be due to various fac-
tors: (i) the Gβγ may be a type that cannot interact with the
AID site (Smrcka, 2008), (ii) the Gαi/o may also interact with
the AID site instead of the Gβγ subunit (Kinoshita et al., 2001),
(iii) the AID site may be phosphorylated by PKC, impeding the
Gβγ interaction (Zamponi and Snutch, 1998), and (iv) the β
subunit may compete with the Gβγ complex for the AID site
(Bourinet et al., 1996). The evaluation of the cAMP pathway
shows that in the VANs, theHVA and LVA ICa inhibition produced
by MOR activation occurs through the VI mechanism; this find-
ing is consistent with previous results reported in the literature
(Law, 2011).
Thus, the MOR modulatory pathway for the ICa inhibition in
the VANs involved a Gαi/o coupled mechanism that, by decreas-
ing the AC activity, led to a reduction in the cAMP levels and
consequently decreased the PKA activity; these effects may ulti-
mately diminish the calcium channel phosphorylation and the
channel open probability (Figure 10). Our results also suggest
that theMOR can also interact with other G proteins, such as Gαq
and Gαs, with no participation of the PKC as a second messenger.
In current clamp experiments, it was thought that the decrease
in the action potential amplitude and the MDR would be caused
by a decrease in the sodium current (INa). However, this idea
is not supported by the experimental data because the fast-
inactivating inward-current in the total current voltage-clamp
FIGURE 10 | MOR activation pathway leading to ICa inhibition in the
VANs. The use of PTX showed that the ICa inhibition by MOR activation is
Gαi/o dependent. Use of paired pulses showed that the VD signaling
mechanism does not significantly participate in the ICa inhibition. The use of
forskolin, 8-Br-cAMP, IBMX, H89, and okadaic acid indicate that the ICa
inhibition (LVA and HVA) by MOR activation is mediated by the cAMP
pathway. Involving the Gαi/o inhibition, AC inhibition, decreased of cAMP
levels, decreased of PKA activity and decreased of PKA-dependent
phosphorylation of calcium channels. In the scheme, arrow-endings indicate
activation and the line-endings indicate inhibition. The names and lines in
red indicate the drugs used. AC, Adenylyl cyclase; GP, G Protein; PDE,
Phosphodiesterase; VD, Voltage dependent signaling mechanism; VGCC,
Voltage gated calcium channels; VI, Voltage independent signaling
mechanism.
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experiments (that is almost completely INa) showed little or no
inhibition by MOR activation. The VANs have a LVA Ca2+ win-
dow current between −65 and −45mV (Autret et al., 2005);
thus, the LVA participate in the depolarization upstroke of the
AP suggesting that changes in the amplitude, and the MDR may
be caused by the inhibition of the LVA component. The change
in the MRR and duration may be secondary to an inhibition of
the calcium dependent potassium current (IK,Ca) (Limón et al.,
2005). In VANs with square-pulse-evoked repetitive discharge,
MOR activation inhibited the discharge in 73% of the cells and
enhanced it in only one neuron. Using sinusoidal stimulation and
MOR agonist application, two types of responses were observed:
one excitatory and the other inhibitory, which indicate that MOR
may exert a complex modulation of the VANs depending on the
expression of currents such as the ICa and the IK,Ca (Limón et al.,
2005; Lysakowski et al., 2011; Meredith et al., 2011). In those neu-
rons with a higher density of IK,Ca, the inhibition of the ICa led
to an increase in excitability because there was a net decrease of
outward current. In contrast, in those neurons with a low density
of the IK,Ca, the inhibition of the ICa predominantly produced
a decrease in the inward current, thus leading to a decrease in
excitability. However, we must consider that MOR and mem-
brane ionic currents of the VAN are coupled, thereby forming
a dynamic network; thus, changes in any of the currents could
result in changes in the activation and eventually may also alter
the dynamics of other currents.
In the central synapse of the VANs within the vestibular
nucleus neurons, the ICa inhibition mediated by the MOR could
significantly modulate the vestibular nucleus neuron gain, thus
significantly contributing to the mechanisms proposed to par-
ticipate in the discrimination of the voluntary head movements
(Cullen, 2012). In addition, in the vestibular compensation pro-
duced after an unilateral labyrentectomy, the inhibition of the
ICa may contribute to vestibular plasticity through the modu-
lation of gene expression (Kitahara et al., 2006; Catterall, 2011;
Beraneck and Idoux, 2012). The accuracy of the vestibular sys-
tem critically depends on the balance between the gains of both
vestibules (Sadeghi et al., 2009; Cullen, 2012). For this to be
achieved, complex mechanisms (formed by the neuronal network
and modulator molecules) able to regulate the network gains are
required. The MOR may act by modulating the VAN operational
range; modifying the postsynaptic signal integration, excitability
and action potential discharge; and the neurotransmitter release
in the afferent synapse at the vestibular nucleus.
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